Skip to main content

What the FDA labels say about taking them together

Estradiol and phenobarbital

Estradiol's FDA label of April 3, 2024 names phenobarbital in its drug interactions section; the phenobarbital labels PlainMeds reads (2) do not name estradiol. The estradiol label: “Inducers of CYP3A4, such as St. John’s wort ( Hypericum perforatum ) preparations, phenobarbital, carbamazepine and rifampin, may reduce plasma concentrations of estrogens, possibly resulting in a decrease in …”

Check it at the source: the estradiol FDA label on DailyMed (effective April 3, 2024, Amneal Pharmaceuticals LLC); the phenobarbital FDA label on DailyMed (effective August 27, 2026).

What does the estradiol label say about phenobarbital?

Estradiol label, drug interactions

Inducers of CYP3A4, such as St. John’s wort ( Hypericum perforatum ) preparations, phenobarbital, carbamazepine and rifampin, may reduce plasma concentrations of estrogens, possibly resulting in a decrease in therapeutic effects and/or changes in the uterine bleeding profile.

Source: FDA drug label (YUVAFEM), Amneal Pharmaceuticals LLC, effective April 3, 2024 (SPL set 30c7f6ba-7a9e-4853-b3e4-e00a46560224), via openFDA; the full label on DailyMed

What does the phenobarbital label say about estradiol?

Phenobarbital's label (effective August 27, 2026) and its 1 other brand-application label do not name estradiol in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Phenobarbital), Chartwell RX, LLC, effective August 27, 2026 (SPL set 74428144-fb24-40a5-a670-3b876e2d116c), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

40Estradiol generic labelers
0Phenobarbital generic labelers
EstradiolPhenobarbital
Labeled forMenopause symptoms, Breast cancer, OsteoporosisSeizures and epilepsy
Boxed warningYesNo
Pharmacy cost (NADAC)$0.0635 per tablet 1 mg tablet$0.213 per tablet 100 mg tablet
Shortage nowNo current entryA presentation being discontinued

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?